Download presentation
Presentation is loading. Please wait.
Published byLindsey Martin Modified over 9 years ago
1
ACE inhibitors, ARBs and Statins in COPD: High- and Low-Risk Cohorts G. B. John Mancini, et al. J Am Coll Cardiol 2006;47:2554-60
2
ACE inhibitors, ARBs and Statins in COPD: Demographics of Cases and Controls in the High-Risk Cohort G. B. John Mancini, et al. J Am Coll Cardiol 2006;47:2554-60
3
ACE inhibitors, ARBs and Statins in COPD: Demographics of Cases and Controls in the Low-Risk Cohort G. B. John Mancini, et al. J Am Coll Cardiol 2006;47:2554-60
4
ACE inhibitors, ARBs and Statins in COPD: Unadjusted Risk Ratios and 95% Confidence Intervals in the High- and Low-Risk COPD Cohorts G. B. John Mancini, et al. J Am Coll Cardiol 2006;47:2554-60
5
ACE inhibitors, ARBs and Statins in COPD: Fully adjusted risk ratios and 95% Confidence Intervals in the High-Risk COPD Cohorts G. B. John Mancini, et al. J Am Coll Cardiol 2006;47:2554-60
6
ACE inhibitors, ARBs and Statins in COPD: Fully adjusted risk ratios and 95% Confidence Intervals in the Low-Risk COPD Cohorts
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.